Supriya Lifescience Limited (NSE:SUPRIYA)

Supriya Lifescience Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,032	760.57	683.49	852.51	1,658	434.98
Short-Term Investments	-	30.97	66.07	723.31	591.55	429.28
Cash & Short-Term Investments	1,032	791.54	749.56	1,576	2,249	864.26
Cash Growth	22.42%	5.60%	-52.43%	-29.94%	160.26%	20.28%
Accounts Receivable	1,551	1,344	1,117	846.64	1,152	735
Other Receivables	30.28	7.1	45.09	64.06	60.32	30.16
Receivables	1,590	1,358	1,169	916.16	1,218	770.44
Inventory	1,428	1,183	852.49	1,158	923.12	724.8
Prepaid Expenses	-	102.43	112.25	108.48	72.45	9.98
Other Current Assets	1,001	935.04	1,097	890.71	512.77	285.15
Total Current Assets	5,051	4,370	3,980	4,649	4,975	2,655
Property, Plant & Equipment	6,288	5,995	4,573	3,281	2,317	1,772
Long-Term Investments	565.48	632.41	637.95	252.96	0.53	0.53
Other Intangible Assets	12.14	13.89	16.56	11.06	15.09	16.13
Other Long-Term Assets	113.43	111.55	6.8	9.28	39.82	11.24
Total Assets	12,030	11,123	9,214	8,203	7,348	4,455
Accounts Payable	763.52	745.46	595.69	642.28	489.72	510.22
Accrued Expenses	-	30.27	29.61	27.58	29.58	34.87
Short-Term Debt	-	-	-	166.25	212.95	674.11
Current Portion of Long-Term Debt	-	-	-	-	-	27.19
Current Portion of Leases	3	3.23	4.68	3.54	8.25	-
Current Income Taxes Payable	-	-50.33	-24.68	45.87	64.11	152
Other Current Liabilities	62.19	92.99	165.76	72.28	192.38	61.8
Total Current Liabilities	828.71	821.62	771.06	957.8	996.99	1,460
Long-Term Leases	49.32	50.57	50.2	54.89	52.95	20.65
Pension & Post-Retirement Benefits	-	-	-	47.3	26.73	13.01
Long-Term Deferred Tax Liabilities	318.38	270.18	231.52	136.75	111.49	80.11
Other Long-Term Liabilities	15.2	13.17	8.03	11.45	2.59	194.87
Total Liabilities	1,212	1,156	1,061	1,208	1,191	1,769
Common Stock	160.97	160.97	160.97	160.97	160.97	146.37
Additional Paid-In Capital	-	1,985	1,985	1,985	1,985	-
Retained Earnings	-	7,820	6,004	4,862	4,011	2,539
Comprehensive Income & Other	10,657	1.57	2.82	-13.42	-0.01	-
Shareholders' Equity	10,818	9,968	8,154	6,995	6,157	2,686
Total Liabilities & Equity	12,030	11,123	9,214	8,203	7,348	4,455
Total Debt	52.32	53.8	54.88	224.68	274.15	721.95
Net Cash (Debt)	979.83	737.74	694.68	1,351	1,975	142.31
Net Cash Growth	24.34%	6.20%	-48.59%	-31.59%	1287.90%	-
Net Cash Per Share	12.19	9.17	8.63	16.79	24.54	1.94
Filing Date Shares Outstanding	80.43	80.48	80.48	80.48	80.48	73.18
Total Common Shares Outstanding	80.43	80.48	80.48	80.48	80.48	73.18
Working Capital	4,222	3,549	3,209	3,691	3,978	1,194
Book Value Per Share	134.51	123.85	101.31	86.91	76.50	36.70
Tangible Book Value	10,806	9,954	8,137	6,984	6,142	2,670
Tangible Book Value Per Share	134.36	123.67	101.10	86.77	76.31	36.48
Land	-	109.23	104.16	91.64	91.6	77.86
Buildings	-	1,291	857.69	724.16	546.76	282.98
Machinery	-	3,810	2,621	2,132	1,474	803.6
Construction In Progress	-	1,480	1,488	676.28	434.09	787.88

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.